Trifecta Capital Advisors’s Colgate-Palmolive CL Stock Holding History

Trifecta Capital Advisors’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-18	Closed	-$1.44K	–	295
2025 Q3	$1.44K	Sell	18 -43	-70%	-$3.67K	﹤0.01%	378
2025 Q2	$5.54K	Buy	61 +43	+239%	+$3.93K	﹤0.01%	263
2025 Q1	$1.69K	Hold	18	–	–	﹤0.01%	328
2024 Q4	$1.64K	Hold	18	–	–	﹤0.01%	324
2024 Q3	$1.87K	Sell	18 -190	-91%	-$19.4K	﹤0.01%	318
2024 Q2	$20.2K	Buy	208 +190	+1,056%	+$17.5K	﹤0.01%	190
2024 Q1	$1.62K	Hold	18	–	–	﹤0.01%	327
2023 Q4	$1.44K	Hold	18	–	–	﹤0.01%	358
2023 Q3	$1.28K	Hold	18	–	–	﹤0.01%	352
2023 Q2	$1.39K	Hold	18	–	–	﹤0.01%	345
2023 Q1	$1.35K	Hold	18	–	–	﹤0.01%	346
2022 Q4	$1.42K	Buy	+18	New	+$1.35K	﹤0.01%	348

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Trifecta Capital Advisors's CL Position: Q4 2025 in Review

Trifecta Capital Advisors sold out of Colgate-Palmolive (CL) in Q4 2025, closing a stake of 18 shares — an estimated $1.44K sold.

Trifecta Capital Advisors first reported a position in CL in Q4 2022 and held it in 12 quarters. The position peaked at $20.2K in Q2 2024. 1,888 funds tracked by Wall St. Rank hold CL as of Q4 2025.

Trifecta Capital Advisors reported no remaining Colgate-Palmolive position as of Q4 2025 after selling out during the quarter.
Trifecta Capital Advisors sold 18 Colgate-Palmolive shares in Q4 2025, an estimated $1.44K.
Trifecta Capital Advisors first reported a position in Colgate-Palmolive in Q4 2022 and held it in 12 quarters.
Trifecta Capital Advisors's Colgate-Palmolive position peaked at $20.2K in Q2 2024.
1,888 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2025.

Based on Trifecta Capital Advisors's 13F filing for Q4 2025, filed 30 Jan 2026.